TLR-dependent T cell activation in autoimmunity
暂无分享,去创建一个
[1] B. Becher,et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. , 2006, The Journal of clinical investigation.
[2] L. Boon,et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.
[3] M. Bevan,et al. Cutting Edge: Lipopolysaccharide Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response , 2007, The Journal of Immunology.
[4] T. Giese,et al. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.
[5] M. Feldmann,et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. , 2007, The American journal of pathology.
[6] V. Tuohy,et al. Encephalitogenicity of Complete Freund’s Adjuvant Relative to CpG Is Linked to Induction of Th17 Cells , 2009, The Journal of Immunology.
[7] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[8] H. Einsele,et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. , 1999, Arthritis and rheumatism.
[9] L. Joosten,et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. , 2006, The Journal of clinical investigation.
[10] E. Sasatomi,et al. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritisin mice , 2000, Immunology.
[11] L. Boon,et al. Infection with a Helminth Parasite Attenuates Autoimmunity through TGF-β-Mediated Suppression of Th17 and Th1 Responses1 , 2009, The Journal of Immunology.
[12] J. Berzofsky,et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.
[13] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[14] S. Akira,et al. Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions1 , 2007, The Journal of Immunology.
[15] D. Fitzgerald,et al. Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-β1 , 2006, The Journal of Immunology.
[16] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[17] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[18] H. Einsele,et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis , 2004, Rheumatology International.
[19] O. Leavy,et al. Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics1 , 2008, The Journal of Immunology.
[20] J. Ruland,et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.
[21] H. Hooijkaas,et al. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. , 1994, Clinical immunology and immunopathology.
[22] B. Segal,et al. IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition , 2008, The Journal of experimental medicine.
[23] B. Lazzaro,et al. Danger, Microbes, and Homeostasis , 2011, Science.
[24] S. Akira,et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.
[25] R. D. Hatton,et al. Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.
[26] Shimon Sakaguchi,et al. Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.
[27] G. Firestein,et al. Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis1 , 2002, The Journal of Immunology.
[28] F. Liew,et al. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. Mills,et al. Inhibition of ERK MAPK Suppresses IL-23- and IL-1-Driven IL-17 Production and Attenuates Autoimmune Disease1 , 2009, The Journal of Immunology.
[30] R. Reynolds,et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.
[31] Clara Abraham,et al. Interactions between the host innate immune system and microbes in inflammatory bowel disease. , 2011, Gastroenterology.
[32] R. J. Hocking,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.
[33] James A. Thomas,et al. Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity , 2006, Journal of Neuroimmunology.
[34] C. Elson,et al. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis , 2010, The Journal of experimental medicine.
[35] D. Strachan. Family size, infection and atopy: the first decade of the 'hygiene hypothesis' , 2000, Thorax.
[36] R. Hirsch,et al. EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.
[37] R. Maizels,et al. T-cell regulation in helminth parasite infections: implications for inflammatory diseases. , 2008, Chemical immunology and allergy.
[38] K. Mills,et al. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours , 2008, Oncogene.
[39] F. Gusovsky,et al. Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist , 2003, Journal of Pharmacology and Experimental Therapeutics.
[40] D. Pardoll,et al. Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance , 2004, Nature Immunology.
[41] A. Mildner,et al. Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2 , 2006, Infection and Immunity.
[42] V. Kuchroo,et al. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. , 2004, The Journal of clinical investigation.
[43] L. Joosten,et al. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. , 2007, Arthritis and rheumatism.
[44] Y. Iwakura,et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.
[45] R Balfour Sartor,et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.
[46] M. Lynch,et al. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis , 2010, Brain, Behavior, and Immunity.
[47] A. Kimball,et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) , 2008, The Lancet.
[48] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[49] K. Mills,et al. TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells1 , 2006, The Journal of Immunology.
[50] Masahiro Yamamoto,et al. ATP drives lamina propria TH17 cell differentiation , 2008, Nature.
[51] K. Mills,et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.
[52] S. Holdsworth,et al. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. , 2011, Arthritis and rheumatism.
[53] P. Tak,et al. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. , 2000, Arthritis and rheumatism.
[54] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[55] H. Wiendl,et al. CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[57] K. Mills,et al. Caspase-1–Processed Cytokines IL-1β and IL-18 Promote IL-17 Production by γδ and CD4 T Cells That Mediate Autoimmunity , 2011, The Journal of Immunology.
[58] Christophe Benoist,et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.
[59] G. Steiner,et al. Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. , 2011, Journal of autoimmunity.
[60] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[61] J. Oppenheim,et al. Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.
[62] Yongsoo Park,et al. Association of the Polymorphism for Toll‐like Receptor 2 with Type 1 Diabetes Susceptibility , 2004, Annals of the New York Academy of Sciences.
[63] K. Kumagai,et al. Induction of Acute Arthritis in Mice by Peptidoglycan Derived from Gram‐Positive Bacteria and Its Possible Role in Cytokine Production , 1993, Microbiology and immunology.
[64] A. Roberts,et al. Regulation of interleukin‐1β by interferon‐γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin‐17 production , 2010, EMBO reports.
[65] L. Tam,et al. Activation profile of Toll‐like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus , 2010, Clinical and experimental immunology.
[66] A. Gurney,et al. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.
[67] L. Joosten,et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. , 2008, The Journal of clinical investigation.
[68] S. Dasgupta,et al. Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression , 2010, The Journal of Immunology.
[69] 박주홍,et al. The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .
[70] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[71] I. Caramalho,et al. Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.
[72] J. Langtry,et al. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas , 2006, Clinical and experimental dermatology.
[73] Weiyi Peng,et al. Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function , 2005, Science.
[74] M. Levings,et al. Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.
[75] C. Tato,et al. Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22 , 2009, The Journal of experimental medicine.
[76] R. Hintzen,et al. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. , 2006, The American journal of pathology.
[77] J. Correale,et al. The risk of relapses in multiple sclerosis during systemic infections , 2006, Neurology.
[78] K. Mills,et al. TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants , 2010, Current infectious disease reports.
[79] T. Owens,et al. Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.
[80] A. Rachitskaya,et al. Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion1 , 2008, The Journal of Immunology.
[81] Xiang Chen,et al. Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.
[82] R. D. Hatton,et al. Regulatory T Cell Suppression and Anergy Are Differentially Regulated by Proinflammatory Cytokines Produced by TLR-Activated Dendritic Cells1 , 2004, The Journal of Immunology.
[83] M. Kurrer,et al. TLR Ligands Act Directly upon T Cells to Restore Proliferation in the Absence of Protein Kinase C-θ Signaling and Promote Autoimmune Myocarditis1 , 2007, The Journal of Immunology.
[84] Thomas Kamradt,et al. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. , 2005, Trends in immunology.
[85] Polly Matzinger,et al. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.
[86] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[87] O. Kämpe,et al. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis , 2008, European journal of immunology.
[88] Chen Dong,et al. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. , 2010, Immunity.
[89] A. Billiau,et al. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.
[90] A. Forbes,et al. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease , 2005, Gut.
[91] T. Merriman,et al. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort , 2007, Journal of gastroenterology and hepatology.
[92] R. Xu,et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. , 2009, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[93] B. Segal,et al. Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease1 , 2002, The Journal of Immunology.
[94] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[95] M. Veldhoen,et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.
[96] Graham M Lord,et al. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes , 2007, Proceedings of the National Academy of Sciences.
[97] R. J. Hocking,et al. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease , 2006, Nature Immunology.
[98] M. Bianchi. DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.
[99] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[100] A. Rachitskaya,et al. NKT cells constitutively express IL‐23 receptor and RORγt, and rapidly produce IL‐17 upon receptor ligation in an IL‐6‐independent fashion , 2008 .
[101] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[102] D. Persing,et al. A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease 1 , 2005, The Journal of Immunology.
[103] W. Hop,et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. , 2002, Brain : a journal of neurology.
[104] A. So,et al. TLR2 modulates inflammation in zymosan-induced arthritis in mice , 2005, Arthritis research & therapy.
[105] R. Ravid,et al. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. , 2001, Brain : a journal of neurology.
[106] K. Mills. Induction, function and regulation of IL‐17‐producing T cells , 2008, European journal of immunology.
[107] W. Born,et al. gammadelta T cells: an important source of IL-17. , 2008, Current opinion in immunology.
[108] S. Akira,et al. TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation , 2006, European journal of immunology.
[109] S. Akira,et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.
[110] D. Hommes,et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.
[111] Andrew E. Parker,et al. Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.
[112] S. Su,et al. Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity , 2005, The Journal of Immunology.
[113] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[114] P. Doevendans,et al. Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .
[115] Kun Wook Chung,et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. , 2007, Immunity.
[116] S. Su,et al. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. , 2010, Investigative ophthalmology & visual science.
[117] R. Ravid,et al. Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.
[118] K. Mills,et al. A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[119] H. Weiner,et al. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE , 2009, Nature Immunology.